8-K filed Jul 24, 2026 at 07:45 ET
HCA Healthcare reported Q2 2026 results consistent with its July 14 preview: revenue of $20.230B (+8.7% YoY) and GAAP EPS of $7.62 (+11.6% YoY), a 1.6% beat vs consensus of $7.50. However, the quarter was marked by a $400M unfavorable payer mix shift from health insurance exchange losses, partially offset by $400M in incremental Medicaid Supplemental Payment Program benefits. Full-year 2026 guidance was revised downward on net income and EPS, reflecting ongoing exchange-related headwinds. Operating cash flow fell sharply to $2.335B from $4.210B a year ago.